Hyperpolarised 13C-Pyruvate MRI Study

NAUnknownINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
CancerCardiovascular Diseases
Interventions
DIAGNOSTIC_TEST

Hyperpolarised MRI

Hyperpolarized (HP) 13C MR is an advanced imaging technique that allows monitoring of dynamic metabolic processes non-invasively. Hyperpolarisation is a process that provides dramatic gains in sensitivity (\>10,000) of MRI signal collected from 13C-labelled substrates that can be injected into living systems, allowing in-vivo metabolism for the first time to be observed in real-time using imaging.

Trial Locations (1)

Unknown

RECRUITING

University College London, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cancer Research UK

OTHER

lead

University College, London

OTHER

NCT03687645 - Hyperpolarised 13C-Pyruvate MRI Study | Biotech Hunter | Biotech Hunter